Health ❯ Healthcare ❯ Research ❯ Clinical Studies

Alzheimer's Research

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Recent studies find plasma p‑tau217 best detects clinical Alzheimer’s while amyloid‑beta misfolding and combined marker panels identify risk years earlier, shaping screening and trial approaches.

4 ARTICLES

4mo ago

Losing Dream Recall Tied to Early Alzheimer’s Signals in Long-Term Study

5 ARTICLES

5mo ago

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

3 ARTICLES

10mo ago

FDA Clears Roche and Lilly’s Elecsys Blood Test to Help Rule Out Alzheimer’s in Symptomatic Adults 55+

15 ARTICLES

10mo ago

Nature Medicine: p‑tau217 Blood Test Accurately Flags Alzheimer’s on Automated Platform

5 ARTICLES

11mo ago

New Blood Tests Enhance Alzheimer's Diagnosis Accuracy

Alzheimer's Research

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Losing Dream Recall Tied to Early Alzheimer’s Signals in Long-Term Study

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

FDA Clears Roche and Lilly’s Elecsys Blood Test to Help Rule Out Alzheimer’s in Symptomatic Adults 55+

Nature Medicine: p‑tau217 Blood Test Accurately Flags Alzheimer’s on Automated Platform

Neuron-Microglia Signal Near Plaques Emerges as a Potential Alzheimer’s Target

NICE Bars New Alzheimer’s Antibodies from NHS Over Cost and Capacity

New Study Reveals Alzheimer's Progresses in Two Distinct Phases

New Insights into Alzheimer's: Beyond Amyloid Beta

New Blood Tests Enhance Alzheimer's Diagnosis Accuracy